Circulating Tumor Material in Colorectal Cancer and Melanoma

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

July 7, 2017

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2020

Conditions
Colorectal Cancer and Melanoma
Interventions
OTHER

blood collection

Patients will receive a research draw for circulating tumor material analysis with standard clinical labs

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02907086 - Circulating Tumor Material in Colorectal Cancer and Melanoma | Biotech Hunter | Biotech Hunter